497
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Pathogen Burden Among ICU Patients in a Tertiary Care Hospital in Hail Saudi Arabia with Particular Reference to β-Lactamases Profile

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, , ORCID Icon, , , & show all
Pages 769-778 | Received 08 Nov 2022, Accepted 16 Jan 2023, Published online: 05 Feb 2023

References

  • Lima J, Alves LR, Paz J, Rabelo MA, Maciel MAV, Morais MMC. Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-associated pneumonia. [Analise da producao de biofilme por isolados clinicos de Pseudomonas aeruginosa de pacientes com pneumonia associada a ventilacao mecanica]. Rev Bras Ter Intensiva. 2017;29(3):310–316. doi:10.5935/0103-507X.20170039
  • Rodrigues ME, Lopes SP, Pereira CR, et al. Polymicrobial ventilator-associated pneumonia: fighting in vitro candida albicans-pseudomonas aeruginosa biofilms with antifungal-antibacterial combination therapy. PLoS One. 2017;12(1):e0170433. doi:10.1371/journal.pone.0170433
  • Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867–903. doi:10.1164/ajrccm.165.7.2105078
  • Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208. doi:10.1186/cc13775
  • Skrupky LP, McConnell K, Dallas J, Kollef MH. A comparison of ventilator-associated pneumonia rates as identified according to the national healthcare safety network and American college of chest physicians criteria. Crit Care Med. 2012;40(1):281–284. doi:10.1097/CCM.0b013e31822d7913
  • Amaral SM, Cortes Ade Q, Pires FR. Nosocomial pneumonia: importance of the oral environment. J Bras Pneumol. 2009;35(11):1116–1124. doi:10.1590/s1806-37132009001100010
  • Torres A, Niederman MS, Chastre J, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J. 2017;50(3). doi:10.1183/13993003.00582-2017
  • Ling L, Wong WT, Lipman J, Joynt GM. A narrative review on the approach to antimicrobial use in ventilated patients with multidrug resistant organisms in respiratory samples-to treat or not to treat? that is the question. Antibiotics. 2022;11(4). doi:10.3390/antibiotics11040452
  • Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115–2121. doi:10.1378/chest.122.6.2115
  • Tille PM. Bailey & Scott’s diagnostic microbiology; 2022.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing. In: CLSI Supplement M100. 30th ed. Clinical and Laboratory Standards Institute, illustrations; 2020:xvi, 72 pages.
  • Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS. Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol. 2007;45(1):227–230. doi:10.1128/JCM.01588-06
  • Matuschek E, Ahman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018;24(8):865–870. doi:10.1016/j.cmi.2017.11.020
  • Satlin MJ. The search for a practical method for colistin susceptibility testing: have we found it by going back to the future? J Clin Microbiol. 2019;57(2). doi:10.1128/JCM.01608-18
  • Kovacevic P, Zlojutro B, Kovacevic T, Baric G, Dragic S, Momcicevic D. Microorganisms profile and antibiotics sensitivity patterns in the only medical intensive care unit in Bosnia and Herzegovina. Microb Drug Resist. 2019;25(8):1176–1181. doi:10.1089/mdr.2018.0458
  • Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik SD. Prevalence of MRSA, ESBL and carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. Int J Curr Microbiol Appl Sci. 2017;6(4):288–299. doi:10.20546/ijcmas.2017.604.032
  • Yusuf I, Rabiu AT, Haruna M, Abdullahi SA. Carbapenem-Resistant Enterobacteriaceae (CRE) in intensive care units and surgical wards of hospitals with no history of carbapenem usage In Kano, North West Nigeria. Nigerian J Microbiol. 2015;27(1):7.
  • Parajuli NP, Acharya SP, Mishra SK, Parajuli K, Rijal BP, Pokhrel BM. High burden of antimicrobial resistance among gram negative bacteria causing healthcare associated infections in a critical care unit of Nepal. Antimicrob Resist Infect Control. 2017;6(1). doi:10.1186/s13756-017-0222-z
  • Cosic G, Djekic J, Rajcevic S, Ristic M, Ikonic N. Nosocomial infections and microbiological agents in an intensive care unit. Arch Biol Sci. 2012;64(4):1357–1362. doi:10.2298/abs1204357c
  • Dasgupta S, Das S, Chawan NS, Hazra A. Nosocomial infections in the intensive care unit: incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India. Indian J Crit Care Med. 2015;19(1):14–20. doi:10.4103/0972-5229.148633
  • Mythri H, Kashinath KR. Nosocomial infections in patients admitted in intensive care unit of a Tertiary Health Center, India. Ann Med Health Sci Res. 2014;4(5):738. doi:10.4103/2141-9248.141540
  • Datta P, Rani H, Chauhan R, Gombar S, Chander J. Health-care-associated infections: risk factors and epidemiology from an intensive care unit in Northern India. Indian J Anaesth. 2014;58(1):30. doi:10.4103/0019-5049.126785
  • Rynga D, Shariff M, Deb M. Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann Clin Microbiol Antimicrob. 2015;14(1). doi:10.1186/s12941-015-0101-5
  • Agarwal R, Gupta D, Ray P, Aggarwal AN, Jindal SK. Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in North India. J Infect. 2006;53(2):98–105. doi:10.1016/j.jinf.2005.10.021
  • Habibi S, Wig N, Agarwal S, et al. Epidemiology of nosocomial infections in medicine intensive care unit at a tertiary care hospital in northern India. Trop Doct. 2008;38(4):233–235. doi:10.1258/td.2008.070395
  • Sah M, Mishra S, Ohara H, Kirikae T, Rijal B, Pokhrel B. Nosocomial bacterial infection and antimicrobial resistant pattern in a tertiary care hospital in Nepal. J Inst Med. 2014;36:38–48.
  • Blot K, Hammami N, Blot S, Vogelaers D, Lambert ML. Seasonal variation of hospital-acquired bloodstream infections: a national cohort study. Infect Control Hosp Epidemiol. 2022;43(2):205–211. doi:10.1017/ice.2021.85
  • Clark JM, Durrani H, Hagan JD, et al. Statewide Seasonal variations of infections within the intensive care unit among the trauma population. Am Surg. 2021;87(4):623–630. doi:10.1177/0003134820951496
  • Herrera-Lara S, Fernández-Fabrellas E, Cervera-Juan Á, Blanquer-Olivas R. Do seasonal changes and climate influence the etiology of community acquired pneumonia? Arch Bronconeumol. 2013;49(4):140–145. doi:10.1016/j.arbr.2013.02.004
  • Mäkinen TM, Juvonen R, Jokelainen J, et al. Cold temperature and low humidity are associated with increased occurrence of respiratory tract infections. Respir Med. 2009;103(3):456–462. doi:10.1016/j.rmed.2008.09.011
  • Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318. doi:10.1179/2047773215y.0000000030
  • Wani FA, Bandy A, Alenzi MJS, et al. Resistance patterns of gram-negative bacteria recovered from clinical specimens of intensive care patients. Microorganisms. 2021;9(11):2246. doi:10.3390/microorganisms9112246
  • Ibrahim ME. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. Saudi Med J. 2018;39(10):1035–1043. doi:10.15537/smj.2018.10.22944
  • Saleem M, Syed Khaja AS, Hossain A, et al. Molecular characterization and antibiogram of acinetobacter baumannii clinical isolates recovered from the patients with ventilator-associated pneumonia. Healthcare. 2022;10(11):2210. doi:10.3390/healthcare10112210
  • Saleem M, Syed Khaja AS, Hossain A, et al. Catheter-associated urinary tract infection in intensive care unit patients at a tertiary care hospital, hail, kingdom of Saudi Arabia. Diagnostics. 2022;12(7):1695. doi:10.3390/diagnostics12071695
  • Pérez-Rodríguez F, Mercanoglu Taban B. A state-of-art review on multi-drug resistant pathogens in foods of animal origin: risk factors and mitigation strategies. Front Microbiol. 2019;10. doi:10.3389/fmicb.2019.02091
  • Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patwardhan NS. Metallo-β-lactamase-producing clinical isolates from patients of a tertiary care hospital. J Lab Physicians. 2020;3(02):093–097. doi:10.4103/0974-2727.86841
  • Kayastha K, Dhungel B, Karki S, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in pediatric patients visiting international friendship children’s hospital, Kathmandu, Nepal. Infect Dis. 2020;13:1178633720909798. doi:10.1177/1178633720909798
  • Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and ampc beta lactamases producing superbugs - havoc in the intensive care units of Punjab India. J Clin Diagn Res. 2013;7(1):70–73. doi:10.7860/JCDR/2012/5016.2673
  • Pilmis B, Zahar J-R. Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli. Ann Transl Med. 2018;6(20):424. doi:10.21037/atm.2018.09.34
  • Confalonieri M, Gorini M, Ambrosino N, Mollica C, Corrado A. Scientific group on respiratory intensive care of the Italian association of hospital P. Respiratory intensive care units in Italy: a national census and prospective cohort study. Thorax. 2001;56(5):373–378. doi:10.1136/thorax.56.5.373
  • Al-Tawfiq JA, Tambyah PA. Healthcare associated infections (HAI) perspectives. J Infect Public Health. 2014;7(4):339–344. doi:10.1016/j.jiph.2014.04.003
  • Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–166. doi:10.1177/003335490712200205
  • Phillips I, Shannon K. Class I ??-Lactamases. Drugs. 1989;37(4):402–407. doi:10.2165/00003495-198937040-00002
  • Giacometti A, Siquini FM, Cirioni O, Petroni S, Scalise G. Imipenem and meropenem induced resistance to beta-lactam antibiotics inPseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis. 1994;13(4):315–318. doi:10.1007/bf01974609